Für diesen Artikel ist leider kein Bild verfügbar.

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

Institute of Medicine, Board on Health Sciences Policy, Development Forum on Drug Discovery and Translation (Autoren)

Anne B. Claiborne, Rebecca A. English (Herausgeber)

Buch | Hardcover

218 Seiten

2014
National Academies Press (Verlag)
978-0-309-38770-5 (ISBN)

Titel ist leider vergriffen;
keine Neuauflage

Artikel merken

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa.

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.

Table of Contents

Front Matter
1 Introduction and Overview of the Workshop
2 The Challenges and Opportunities for the BRICS Countries to Lead
3 Catching Up with the Microbe
4 Drug-Resistant TB in China
5 Experiences with MDR TB in Other Countries
6 Drug-Resistant Tuberculosis in Pediatric Populations
7 Global Perspectives on Transmission and Infection Control
8 Rapid Diagnostic Technologies: Status and Limitations
9 Addressing Diagnosis and Treatment Across the Spectrum of Drug Resistance
10 Developing and Strengthening the Drug Supply Chain for Drug-Resistant TB
11 Embracing a New Vision for Research
12 What Will Be Required to Achieve Zero Deaths from TB?
13 Creating an Evidence-Based Blueprint for Action
References
Appendix A: Workshop Agenda
Appendix B: Participant Biographies

1 Front Matter; 2 1 Introduction and Overview of the Workshop; 3 2 The Challenges and Opportunities for the BRICS Countries to Lead; 4 3 Catching Up with the Microbe; 5 4 Drug-Resistant TB in China; 6 5 Experiences with MDR TB in Other Countries; 7 6 Drug-Resistant Tuberculosis in Pediatric Populations; 8 7 Global Perspectives on Transmission and Infection Control; 9 8 Rapid Diagnostic Technologies: Status and Limitations; 10 9 Addressing Diagnosis and Treatment Across the Spectrum of Drug Resistance; 11 10 Developing and Strengthening the Drug Supply Chain for Drug-Resistant TB; 12 11 Embracing a New Vision for Research; 13 12 What Will Be Required to Achieve Zero Deaths from TB?; 14 13 Creating an Evidence-Based Blueprint for Action; 15 References; 16 Appendix A: Workshop Agenda; 17 Appendix B: Participant Biographies

Erscheint lt. Verlag	28.2.2014
Verlagsort	Washington
Sprache	englisch
Maße	152 x 229 mm
Themenwelt	Medizin / Pharmazie ► Gesundheitswesen
	Medizin / Pharmazie ► Medizinische Fachgebiete
	Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung
ISBN-10	0-309-38770-1 / 0309387701
ISBN-13	978-0-309-38770-5 / 9780309387705
Zustand	Neuware